SCHEMBL3779346

SCHEMBL3779346

Cc1cccc(OCC(=O)N2CCN(CC(=O)N3CCN(C4CCC4)CC3)CC2)c1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 0.72
CYP2D6 P10635 1/20 0.72
CYP2C19 P33261 1/20 0.72
KDM4E B2RXH2 8/20 0.66
ALDH1A1 P00352 8/20 0.61
LMNA P02545 1/20 0.61
RECQL P46063 1/20 0.57
KMT2A Q03164 3/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
MAPT P10636 2/20 0.56
NPC1 O15118 1/20 0.56
TP53 P04637 1/20 0.56
RAB9A P51151 1/20 0.56
MEN1 O00255 2/20 0.56
TDP1 Q9NUW8 1/20 0.55
GAA P10253 1/20 0.54
TSHR P16473 1/20 0.54
HTT P42858 1/20 0.53
MAPK1 P28482 2/20 0.53
ACHE P22303 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3776429 0.90 GAA (0.61) NPSR1CYP2D6CYP2C19KDM4EALDH1A1
SCHEMBL3767792 0.88 KDM4E (0.59) NPSR1CYP2D6CYP2C19KDM4EKMT2A
SCHEMBL3774181 0.87 KDM4E (0.78) KDM4EALDH1A1LMNAKMT2ASMN1; SMN2
SCHEMBL14608986 0.85 NPSR1 (0.60) NPSR1CYP2D6CYP2C19KDM4EALDH1A1
SCHEMBL3767950 0.84 SMN1; SMN2 (0.70) CYP2D6CYP2C19KDM4EALDH1A1LMNA
SCHEMBL3779219 0.83 POLB (0.60) NPSR1CYP2D6CYP2C19KDM4EALDH1A1
SCHEMBL3773808 0.83 SMN1; SMN2 (0.63) NPSR1CYP2D6CYP2C19KDM4EALDH1A1
SCHEMBL3767766 0.83 ACHE (0.68) KDM4EALDH1A1KMT2ASMN1; SMN2TSHR
SCHEMBL3769014 0.82 KDM4E (0.55) NPSR1CYP2D6CYP2C19KDM4ESMN1; SMN2
SCHEMBL3774399 0.82 POLB (0.62) NPSR1CYP2D6CYP2C19KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7851474-B2 Dipiperazinyl ketones and related analogues NEUROGEN CORPORATION (US) 2010-12-14 US disclosed
US-7851474-B2 Dipiperazinyl ketones and related analogues NEUROGEN CORPORATION (US) 2010-12-14 US disclosed
US-7851474-B2 Dipiperazinyl ketones and related analogues NEUROGEN CORPORATION (US) 2010-12-14 US disclosed
US-20070049571-A1 Dipiperazinyl ketones and related analogues NEUROGEN CORPORATION 2007-03-01 US disclosed
US-20070049571-A1 Dipiperazinyl ketones and related analogues NEUROGEN CORPORATION 2007-03-01 US disclosed
US-20070049571-A1 Dipiperazinyl ketones and related analogues NEUROGEN CORPORATION 2007-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070049571-A1 Dipiperazinyl ketones and related analogues HRH4, HRH3, HRH1 NPSR1 357/4885CYP2D6 1492/4885CYP2C19 1971/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.